Levin T R, Palitz A, Grossman S, Conell C, Finkler L, Ackerson L, Rumore G, Selby J V
Division of Research, Kaiser Permanente Medical Care Program, Oakland, Calif, USA.
JAMA. 1999 May 5;281(17):1611-7. doi: 10.1001/jama.281.17.1611.
Indications are not well defined for follow-up colonoscopy for all patients with distal colonic tubular adenomas (TAs) found at screening sigmoidoscopy.
To determine whether distal adenoma size, number, and villous histology, along with family history and age, are predictors of advanced proximal colonic neoplasia.
Cross-sectional analysis conducted between January 1, 1994, and December 31, 1995.
Large group-model health maintenance organization in northern California.
A total of 2972 asymptomatic subjects aged 50 years or older undergoing colonoscopy as follow-up to a screening sigmoidoscopy.
Based on sigmoidoscopy, colonoscopy, and pathology reports, occurrence of advanced proximal neoplasia, defined as adenocarcinoma or TAs 1 cm or larger or with villous features or severe dysplasia located beyond sigmoidoscopic view.
The prevalence of advanced proximal neoplasia was similar among patients with no TAs at sigmoidoscopy, those with TAs less than 1 cm in diameter, and those with TAs 1 cm in diameter or larger (prevalence, 5.3%, 5.5%, and 5.6%, respectively). Of patients with a distal tubulovillous or villous adenoma, 12.1% had advanced proximal neoplasia. In multivariate analyses, having a distal tubulovillous adenoma or villous adenoma was the strongest predictor of advanced proximal neoplasia (odds ratio, 2.30; 95% confidence interval, 1.69-3.14). Age of 65 years or older, having more than 1 adenoma, and a positive family history of colorectal cancer were also significant predictors. Distal adenoma size was not a significant predictor in any multivariate analyses.
Advanced proximal neoplasia is not uncommon in subjects with or without distal TAs, but subjects with advanced distal histology and those older than 65 years are at increased risk. Age-specific screening using sigmoidoscopy starting at ages 50 to 55 years and colonoscopy after age 65 years may be justified.
对于在乙状结肠镜筛查中发现远端结肠管状腺瘤(TA)的所有患者,后续结肠镜检查的适应证尚未明确界定。
确定远端腺瘤大小、数量、绒毛组织学特征,以及家族史和年龄是否为近端结肠高级别肿瘤的预测因素。
1994年1月1日至1995年12月31日进行的横断面分析。
北加利福尼亚的大型团体模式健康维护组织。
共有2972名50岁及以上的无症状受试者接受结肠镜检查,作为乙状结肠镜筛查的后续检查。
根据乙状结肠镜检查、结肠镜检查和病理报告,确定近端高级别肿瘤的发生情况,近端高级别肿瘤定义为腺癌或直径1厘米及以上的TA,或具有绒毛特征或严重发育异常且位于乙状结肠镜视野以外的病变。
在乙状结肠镜检查未发现TA的患者、直径小于1厘米TA的患者以及直径1厘米及以上TA的患者中,近端高级别肿瘤的患病率相似(患病率分别为5.3%、5.5%和5.6%)。远端小管绒毛状或绒毛状腺瘤患者中,12.1%患有近端高级别肿瘤。在多因素分析中,患有远端小管绒毛状腺瘤或绒毛状腺瘤是近端高级别肿瘤最强的预测因素(比值比为2.30;95%置信区间为1.69-3.14)。65岁及以上、腺瘤数量超过1个以及有结直肠癌家族史也是显著的预测因素。在任何多因素分析中,远端腺瘤大小均不是显著的预测因素。
无论有无远端TA,近端高级别肿瘤在受试者中并不罕见,但具有高级别远端组织学特征的受试者和65岁以上的受试者风险增加。从50至55岁开始使用乙状结肠镜进行年龄特异性筛查,65岁以后进行结肠镜检查可能是合理的。